It’s not just the development of a COVID-19 vaccine that’s challenging – it’s the manufacturing, too. But how does the protection of Intellectual Property play into this purpose driven mission? Valneva CFO David Lawrence shares how they’ve been able to move quickly in ‘Vaccinating the Nation’ - the first in our series of Corporate Clarity Talks.
The content of this webpage is for information only and is not intended to be construed as legal advice and should not be treated as a substitute for specific advice. Morton Fraser LLP accepts no responsibility for the content of any third party website to which this webpage refers. Morton Fraser LLP is authorised and regulated by the Financial Conduct Authority.